Skip to main content
SpringerLink
Log in

Epidemiology of Skin Cancer: Update 2019

  • Chapter
  • First Online:
Book cover Sunlight, Vitamin D and Skin Cancer

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1268))

Abstract

Melanoma and keratinocyte skin cancer (KSC) are the most common types of cancer in White-skinned populations. Both tumor entities showed increasing incidence rates worldwide but stable or decreasing mortality rates. Rising incidence rates of cutaneous melanoma (CM) and KSC are largely attributed to increasing exposure to ultraviolet (UV) radiation, the main causal risk factor for skin cancer.

Incidence rates of KSC, comprising of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are much higher than that of melanoma. BCC development is mainly the cause of an intensive UV exposure in childhood and adolescence, while SCC development is related to chronic, cumulative UV exposure over decades. Although mortality is relatively low, KSC is an increasing problem for health care services causing significant morbidity.

Cutaneous melanoma is rapidly increasing in White populations, with an estimated annual increase of around 3–7% over the past decades. In contrast to SCC, melanoma risk is associated with intermittent and chronic exposure to sunlight. The frequency of its occurrence is closely associated with the constitutive color of the skin and the geographical zone. Changes in outdoor activities and exposure to sunlight during the past 70 years are an important factor for the increasing incidence of melanoma. Mortality rates of melanoma show stabilization in the USA, Australia, and in European countries. In the USA even dropping numbers of death cases were recently reported, probably reflecting efficacy of the new systemic treatments.

Among younger cohorts in some populations (e.g., Australia and New Zealand,), stabilizing or declining incidence rates of CM are observed, potentially caused by primary prevention campaigns aimed at reducing UV exposure. In contrast, incidence rates of CM are still rising in most European countries and in the USA. Ongoing trends towards thinner melanoma are largely ascribed to earlier detection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res. 1993;3(6):395–401.

    Article  CAS  PubMed  Google Scholar 

  2. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE, et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res. 2014;20(24):6582–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50(1):7–33.

    Article  CAS  PubMed  Google Scholar 

  5. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.

    Article  PubMed  Google Scholar 

  6. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.

    Article  PubMed  Google Scholar 

  7. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.

    Article  PubMed  Google Scholar 

  8. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.

    Article  PubMed  Google Scholar 

  9. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.

    Article  PubMed  Google Scholar 

  10. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.

    Article  PubMed  Google Scholar 

  11. Silverberg E. Cancer statistics, 1985. CA Cancer J Clin. 1985;35(1):19–35.

    Article  CAS  PubMed  Google Scholar 

  12. Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990. CA Cancer J Clin. 1990;40(1):9–26.

    Article  CAS  PubMed  Google Scholar 

  13. Cancer statistics, 1975. CA Cancer J Clin. 1975;25(1):8–21.

    Google Scholar 

  14. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55(1):10–30.

    Article  PubMed  Google Scholar 

  15. Silverberg E. Cancer statistics, 1980. CA Cancer J Clin. 1980;30(1):23–38.

    Article  CAS  PubMed  Google Scholar 

  16. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 1995;45(1):8–30.

    Article  CAS  PubMed  Google Scholar 

  17. Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012. JAMA Dermatol 2015.

    Google Scholar 

  18. Garbe C, Keim U, Eigentler TK, Amaral T, Katalinic A, Holleczek B, et al. Time trends in incidence and mortality of cutaneous melanoma in Germany. J Eur Acad Dermatol Venereol. 2018.

    Google Scholar 

  19. Leiter U, Keim U, Eigentler T, Katalinic A, Holleczek B, Martus P, et al. Incidence, mortality, and trends of nonmelanoma skin Cancer in Germany. J Invest Dermatol. 2017;137(9):1860–7.

    Article  CAS  PubMed  Google Scholar 

  20. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069–80.

    Article  CAS  PubMed  Google Scholar 

  21. Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R, et al. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol. 2014;134(1):43–50.

    Article  CAS  PubMed  Google Scholar 

  22. Donaldson MR, Coldiron BM. No end in sight: the skin cancer epidemic continues. Semin Cutan Med Surg. 2011;30(1):3–5.

    Article  CAS  PubMed  Google Scholar 

  23. Rudolph C, Schnoor M, Eisemann N, Katalinic A. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. J Dtsch Dermatol Ges. 2015;13(8):788–97.

    PubMed  Google Scholar 

  24. Birch-Johansen F, Jensen A, Mortensen L, Olesen AB, Kjaer SK. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978–2007: rapid incidence increase among young Danish women. Int J Cancer. 2010;127(9):2190–8.

    Article  CAS  PubMed  Google Scholar 

  25. Brewster DH, Bhatti LA, Inglis JH, Nairn ER, Doherty VR. Recent trends in incidence of nonmelanoma skin cancers in the east of Scotland, 1992–2003. Br J Dermatol. 2007;156(6):1295–300.

    Article  CAS  PubMed  Google Scholar 

  26. Muzic JG, Schmitt AR, Wright AC, Alniemi DT, Zubair AS, Olazagasti Lourido JM, et al. Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010. Mayo Clin Proc. 2017;92(6):890–8.

    Article  PubMed  Google Scholar 

  27. Perera E, Gnaneswaran N, Staines C, Win AK, Sinclair R. Incidence and prevalence of non-melanoma skin cancer in Australia: a systematic review. Australas J Dermatol. 2015;56(4):258–67.

    Article  PubMed  Google Scholar 

  28. Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol. 2014;810:120–40.

    PubMed  Google Scholar 

  29. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184(1):6–10.

    Article  PubMed  Google Scholar 

  30. Pandeya N, Olsen CM, Whiteman DC. The incidence and multiplicity rates of keratinocyte cancers in Australia. Med J Aust. 2017;207(8):339–43.

    Article  PubMed  Google Scholar 

  31. GEKID. Gesellschaft der epidemiologischen Krebsregsister in Deutschland e.V. (GEKID) 2019. Available from: https://www.gekid.de/

  32. Stang A, Jockel KH, Heidinger O. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000–2015). Eur J Epidemiol. 2018;33(3):303–12.

    Article  PubMed  Google Scholar 

  33. IARC. IARC International Agency for Research on Cancer: cancer in five continents, Lyon (France) Lyon (France)2019. Available from: http://www.ci5.iarc.fr

  34. Saarland Cancer Registry. Krebsregister Saarland, Germany 2019. Available from: http://www.krebsregister.saarland.de/datenbank/datenbank.html

  35. Venables ZC, Nijsten T, Wong KF, Autier P, Broggio J, Deas A, et al. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013–15: a cohort study. Br J Dermatol. 2019.

    Google Scholar 

  36. ISD. ISD Scotland, Scotland Cancer Registry: Cancer Statistics, Skin Cancer 2019. Available from: https://www.isdscotland.org/Health-Topics/Cancer/Cancer-Statistics/Skin

  37. Robert Koch Institut Berlin. Die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg) (2017) Krebs in Deutschland 2013/2014, 11. Ausgabe Berlin 2017.

    Google Scholar 

  38. Garcovich S, Colloca G, Sollena P, Andrea B, Balducci L, Cho WC, et al. Skin Cancer epidemics in the elderly as an emerging issue in geriatric oncology. Aging Dis. 2017;8(5):643–61.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Lewis KG, Weinstock MA. Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000. J Invest Dermatol. 2007;127(10):2323–7.

    Article  CAS  PubMed  Google Scholar 

  40. Lewis KG, Weinstock MA. Nonmelanoma skin cancer mortality (1988–2000): the Rhode Island follow-back study. Arch Dermatol. 2004;140(7):837–42.

    Article  PubMed  Google Scholar 

  41. Weinstock MA. Epidemiologic investigation of nonmelanoma skin cancer mortality: the Rhode Island Follow-Back Study. J Invest Dermatol. 1994;102(6):6s–9s.

    Article  CAS  PubMed  Google Scholar 

  42. Stang A, Jockel KH. Declining mortality rates for nonmelanoma skin cancers in West Germany, 1968–99. Br J Dermatol. 2004;150(3):517–22.

    Article  CAS  PubMed  Google Scholar 

  43. Hollestein LM, de Vries E, Nijsten T. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989–2008. Eur J Cancer. 2012;48(13):2046–53.

    Article  CAS  PubMed  Google Scholar 

  44. Wehner MR, Cidre Serrano W, Nosrati A, Schoen PM, Chren MM, Boscardin J, et al. All-cause mortality in patients with basal and squamous cell carcinoma: a systematic review and meta-analysis. J Am Acad Dermatol. 2018;78(4):663–72.e3.

    Google Scholar 

  45. Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, et al. Survival with nonmelanoma skin cancer in Germany. Br J Dermatol. 2016;174(4):778–85.

    Article  CAS  PubMed  Google Scholar 

  46. Jensen A, Bautz A, Olesen A, Karagas M, Sørensen H, Friis S. Mortality in Danish patients with nonmelanoma skin cancer, 1978–2001. Br J Dermatol. 2008;159(2):419–25.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Rees JR, Zens MS, Celaya MO, Riddle BL, Karagas MR, Peacock JL. Survival after squamous cell and basal cell carcinoma of the skin: a retrospective cohort analysis. Int J Cancer. 2015;137(4):878–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30(5 Pt 1):774–8.

    Article  CAS  PubMed  Google Scholar 

  49. Chahal HS, Rieger KE, Sarin KY. Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age. J Am Acad Dermatol. 2017;76(2):353–4.

    Article  PubMed  Google Scholar 

  50. Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin Cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol. 2015;151(10):1081–6.

    Article  PubMed  Google Scholar 

  51. Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol. 2003;149(6):1200–6.

    Article  CAS  PubMed  Google Scholar 

  52. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146(Suppl 61):1–6.

    Article  PubMed  Google Scholar 

  53. Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. Adv Exp Med Biol. 2008;624:89–103.

    Article  PubMed  Google Scholar 

  54. Brantsch KD, Meisner C, Schönfisch B, Trilling B, Wehner-Caroli J, Röcken M, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713–20.

    Article  PubMed  Google Scholar 

  55. Kricker A, Armstrong BK, English DR. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control. 1994;5(4):367–92.

    Article  CAS  PubMed  Google Scholar 

  56. Kricker A, Armstrong BK, English DR, Heenan PJ. Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer. 1995;60(4):489–94.

    Article  CAS  PubMed  Google Scholar 

  57. de Villiers EM. Human papillomavirus infections in skin cancers. Biomed Pharmacother. 1998;52(1):26–33.

    Article  PubMed  Google Scholar 

  58. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A. 1993;90(9):4216–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Zhang H, Ping XL, Lee PK, Wu XL, Yao YJ, Zhang MJ, et al. Role of PTCH and p53 genes in early-onset basal cell carcinoma. Am J Pathol. 2001;158(2):381–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Athar M, Tang X, Lee JL, Kopelovich L, Kim AL. Hedgehog signalling in skin development and cancer. Exp Dermatol. 2006;15(9):667–77.

    Article  CAS  PubMed  Google Scholar 

  61. Daya-Grosjean L, Sarasin A. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutat Res. 2005;571(1–2):43–56.

    Article  CAS  PubMed  Google Scholar 

  62. Situm M, Levanat S, Crnic I, Pavelic B, Macan D, Grgurevic J, et al. Involvement of patched (PTCH) gene in Gorlin syndrome and related disorders: three family cases. Croat Med J. 1999;40(4):533–8.

    CAS  PubMed  Google Scholar 

  63. Ping XL, Ratner D, Zhang H, Wu XL, Zhang MJ, Chen FF, et al. PTCH mutations in squamous cell carcinoma of the skin. J Invest Dermatol. 2001;116(4):614–6.

    Article  CAS  PubMed  Google Scholar 

  64. Schmitt J, Seidler A, Diepgen TL, Bauer A. Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis. Br J Dermatol. 2011;164(2):291–307.

    Article  CAS  PubMed  Google Scholar 

  65. Bauer A, Diepgen TL, Schmitt J. Is occupational solar ultraviolet irradiation a relevant risk factor for basal cell carcinoma? A systematic review and meta-analysis of the epidemiological literature. Br J Dermatol. 2011;165(3):612–25.

    CAS  PubMed  Google Scholar 

  66. Diepgen TL. Occupational skin diseases. J Dtsch Dermatol Ges. 2012;10(5):297–313.. quiz 4–5

    PubMed  Google Scholar 

  67. Diepgen TL, Fartasch M, Drexler H, Schmitt J. Occupational skin cancer induced by ultraviolet radiation and its prevention. Br J Dermatol. 2012;167(Suppl 2):76–84.

    Article  PubMed  Google Scholar 

  68. de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer. 2004;40(16):2355–66.

    Article  PubMed  Google Scholar 

  69. Erdmann F, Lortet-Tieulent J, Schuz J, Zeeb H, Greinert R, Breitbart EW, et al. International trends in the incidence of malignant melanoma 1953–2008--are recent generations at higher or lower risk? Int J Cancer. 2013;132(2):385–400.

    Article  CAS  PubMed  Google Scholar 

  70. Forsea AM, Del Marmol V, de Vries E, Bailey EE, Geller AC. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol. 2012;167(5):1124–30.

    Article  CAS  PubMed  Google Scholar 

  71. Karimkhani C, Green AC, Nijsten T, Weinstock MA, Dellavalle RP, Naghavi M, et al. The global burden of melanoma: results from Global Burden of Disease Study 2015. Br J Dermatol 2017.

    Google Scholar 

  72. Nikolaou V, Stratigos AJ. Emerging trends in the epidemiology of melanoma. Br J Dermatol. 2014;170(1):11–9.

    Article  CAS  PubMed  Google Scholar 

  73. Arnold M, Holterhues C, Hollestein LM, Coebergh JW, Nijsten T, Pukkala E, et al. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol. 2014;28(9):1170–8.

    Article  CAS  PubMed  Google Scholar 

  74. Glazer AM, Winkelmann RR, Farberg AS, Rigel DS. Analysis of Trends in US Melanoma Incidence and Mortality. JAMA Dermatol. 2016.

    Google Scholar 

  75. Holman DM, Freeman MB, Shoemaker ML. Trends in melanoma incidence among non-Hispanic whites in the United States, 2005 to 2014. JAMA Dermatol. 2018;154(3):361–2.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Jemal A, Saraiya M, Patel P, Cherala SS, Barnholtz-Sloan J, Kim J, et al. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992–2006. J Am Acad Dermatol. 2011;65(5 Suppl 1):S17–25.e1–3.

    Google Scholar 

  77. Fuglede NB, Brinck-Claussen UO, Deltour I, Boesen EH, Dalton SO, Johansen C. Incidence of cutaneous malignant melanoma in Denmark, 1978–2007. Br J Dermatol. 2011;165(2):349–53.

    Article  CAS  PubMed  Google Scholar 

  78. Helvind NM, Holmich LR, Smith S, Glud M, Andersen KK, Dalton SO, et al. Incidence of in situ and invasive melanoma in Denmark from 1985 through 2012: a National Database Study of 24,059 melanoma cases. JAMA Dermatol. 2015;151(10):1087–95.

    Article  PubMed  Google Scholar 

  79. Aitken JF, Youlden DR, Baade PD, Soyer HP, Green AC, Smithers BM. Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995–2014. Int J Cancer. 2018;142(8):1528–35.

    Article  CAS  PubMed  Google Scholar 

  80. Olsen CM, Green AC, Pandeya N, Whiteman DC. Trends in melanoma incidence rates in eight susceptible populations to 2015. J Invest Dermatol 2018.

    Google Scholar 

  81. Whiteman DC, Green AC, Olsen CM. The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Invest Dermatol. 2016;136(6):1161–71.

    Article  CAS  PubMed  Google Scholar 

  82. Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 2018.

    Google Scholar 

  83. de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003;107(1):119–26.

    Article  PubMed  CAS  Google Scholar 

  84. Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. Lancet. 2014;383(9919):816–27.

    Article  CAS  PubMed  Google Scholar 

  85. AIHW. AIHW Australian Institute of Health and Welfare: Cancer Incidence Data 2019. Available from: https://www.aihw.gov.au/reports/

  86. SEER. Surveillance, Epidemiology, End Results (SEER) Program: SEER∗Stat Database: incidence-SEER 9 Registries Research Data 2019. Available from: http://www.seer.cancer.gov

  87. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27(1):3–9.

    Article  PubMed  Google Scholar 

  88. ECIS. ECIS-European Cancer Information System. Data explorer. Incidence and mortality statistics 2019. Available from: https://ecis.jrc.ec.europa.eu/

  89. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al. NORDCAN--a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725–36.

    Article  PubMed  Google Scholar 

  90. Engholm G, Ferlay J, Christensen N, Hansen HL, Hertzum-Larsen R, Johannesen TB, et al. NORDCAN-Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.1 (28.06.2018). Association of the Nordic Cancer Registries. Danish Cancer Society 2019. Available from: http://www.ancr.nu

  91. NORDCAN. NORDCAN Project - Cancer Statistics for the Nordic Countries 2019. Available from: http://www-dep.iarc.fr/NORDCAN

  92. Bay C, Kejs AM, Storm HH, Engholm G. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish population-based register study 1989–2011. Cancer Epidemiol. 2015;39(1):1–7.

    Article  PubMed  Google Scholar 

  93. Guy GP Jr, Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC. Vital signs: melanoma incidence and mortality trends and projections – United States, 1982-2030. MMWR Morb Mortal Wkly Rep. 2015;64(21):591–6.

    PubMed  PubMed Central  Google Scholar 

  94. Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res. 2004;14(4):301–9.

    Article  PubMed  Google Scholar 

  95. Autier P, Koechlin A, Boniol M. The forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populations. Eur J Cancer. 2015;51(7):869–78.

    Article  PubMed  Google Scholar 

  96. Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer. 2000;82(11):1887–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Barbaric J, Sekerija M, Agius D, Coza D, Dimitrova N, Demetriou A, et al. Disparities in melanoma incidence and mortality in South-Eastern Europe: increasing incidence and divergent mortality patterns. Is progress around the corner? Eur J Cancer. 2016;55:47–55.

    Article  PubMed  Google Scholar 

  98. Boniol M, Autier P, Gandini S. Melanoma mortality following skin cancer screening in Germany. BMJ Open. 2015;5(9):e008158.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Marks R. The changing incidence and mortality of melanoma in Australia. Recent Results Cancer Res. 2002;160:113–21.

    Article  PubMed  Google Scholar 

  100. Montella A, Gavin A, Middleton R, Autier P, Boniol M. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland. Eur J Cancer. 2009;45(13):2360–6.

    Article  PubMed  Google Scholar 

  101. McKinnon JG, Yu XQ, McCarthy WH, Thompson JF. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales central Cancer registry and the Sydney melanoma unit. Cancer. 2003;98(6):1223–31.

    Article  PubMed  Google Scholar 

  102. Lyth J, Eriksson H, Hansson J, Ingvar C, Jansson M, Lapins J, et al. Trends in cutaneous malignant melanoma in Sweden 1997–2011: thinner tumours and improved survival among men. Br J Dermatol. 2015;172(3):700–6.

    Article  CAS  PubMed  Google Scholar 

  103. Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, et al. Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer. 2018.

    Google Scholar 

  104. Buettner PG, Leiter U, Eigentler TK, Garbe C. Development of prognostic factors and survival in cutaneous melanoma over 25 years: an analysis of the central malignant melanoma registry of the German dermatological society. Cancer. 2005;103(3):616–24.

    Article  PubMed  Google Scholar 

  105. Schwager SS, Leiter U, Buettner PG, Voit C, Marsch W, Gutzmer R, et al. Management of primary and metastasized melanoma in Germany in the time period 1976–2005: an analysis of the central malignant melanoma registry of the German dermatological society. Melanoma Res. 2008;18(2):112–9.

    Article  PubMed  Google Scholar 

  106. Geller AC, Miller DR, Annas GD, Demierre MF, Gilchrest BA, Koh HK. Melanoma incidence and mortality among US whites, 1969–1999. JAMA. 2002;288(14):1719–20.

    Article  PubMed  Google Scholar 

  107. MacKie RM, Bray CA, Hole DJ, Morris A, Nicolson M, Evans A, et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet. 2002;360(9333):587–91.

    Article  PubMed  Google Scholar 

  108. Lasithiotakis KG, Leiter U, Gorkievicz R, Eigentler T, Breuninger H, Metzler G, et al. The incidence and mortality of cutaneous melanoma in southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer. 2006;107(6):1331–9.

    Article  PubMed  Google Scholar 

  109. Yuan TA, Lu Y, Edwards K, Jakowatz J, Meyskens FL, Liu-Smith F. Race-, Age-, and Anatomic Site-Specific Gender Differences in Cutaneous Melanoma Suggest Differential Mechanisms of Early- and Late-Onset Melanoma. Int J Environ Res Public Health. 2019;16(6).

    Google Scholar 

  110. Whiteman DC, Stickley M, Watt P, Hughes MC, Davis MB, Green AC. Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol. 2006;24(19):3172–7.

    Article  PubMed  Google Scholar 

  111. Siskind V, Whiteman DC, Aitken JF, Martin NG, Green AC. An analysis of risk factors for cutaneous melanoma by anatomical site (Australia). Cancer Causes Control. 2005;16(3):193–9.

    Article  PubMed  Google Scholar 

  112. Caini S, Gandini S, Sera F, Raimondi S, Fargnoli MC, Boniol M, et al. Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer. 2009;45(17):3054–63.

    Article  PubMed  Google Scholar 

  113. Crocetti E, Carli P. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness. Eur J Dermatol. 2003;13(1):72–5.

    PubMed  Google Scholar 

  114. Leiter U, Buettner PG, Eigentler TK, Garbe C. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the German dermatological society. J Clin Oncol. 2004;22(18):3660–7.

    Article  PubMed  Google Scholar 

  115. El Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V, et al. A review of human carcinogens--part D: radiation. Lancet Oncol. 2009;10(8):751–2.

    Article  PubMed  Google Scholar 

  116. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. A review of Human Carcinogens. IARC Monographs Radiation, Lyon (France): World Health Organisation. 2012;100D.

    Google Scholar 

  117. Parkin DM, Mesher D, Sasieni P. 13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010. Br J Cancer. 2011;105 Suppl 2:S66–9.

    Google Scholar 

  118. Arnold M, de Vries E, Whiteman DC, Jemal A, Bray F, Parkin DM, et al. Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012. Int J Cancer 2018.

    Google Scholar 

  119. Lucas RM, McMichael AJ, Armstrong BK, Smith WT. Estimating the global disease burden due to ultraviolet radiation exposure. Int J Epidemiol. 2008;37(3):654–67.

    Article  PubMed  Google Scholar 

  120. Olsen CM, Wilson LF, Green AC, Bain CJ, Fritschi L, Neale RE, et al. Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use. Aust N Z J Public Health. 2015;39(5):471–6.

    Article  PubMed  PubMed Central  Google Scholar 

  121. Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31–54.

    Article  PubMed  Google Scholar 

  122. Arnold M, Kvaskoff M, Thuret A, Guenel P, Bray F, Soerjomataram I. Cutaneous melanoma in France in 2015 attributable to solar ultraviolet radiation and the use of sunbeds. J Eur Acad Dermatol Venereol. 2018;32:1681.

    Article  CAS  PubMed  Google Scholar 

  123. Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105 Suppl 2:S77–81.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Dermatooncology, Department of Dermatology, University Medical Center, Tuebingen, Germany

    Ulrike Leiter, Ulrike Keim & Claus Garbe

Authors
  1. Ulrike Leiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrike Keim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Claus Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claus Garbe .

Editor information

Editors and Affiliations

  1. Center for Clinical and Experimental Photodermatology and Department of Dermatology, Saarland University Medical Center, Homburg, Germany

    Jörg Reichrath

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Leiter, U., Keim, U., Garbe, C. (2020). Epidemiology of Skin Cancer: Update 2019. In: Reichrath, J. (eds) Sunlight, Vitamin D and Skin Cancer. Advances in Experimental Medicine and Biology, vol 1268. Springer, Cham. https://doi.org/10.1007/978-3-030-46227-7_6

Download citation

Publish with us

Policies and ethics

Search

Navigation